V Drozdovitch1, V V Yauseyenka2, V F Minenko3, I V Veyalkin2, T S Kukhta4, R I Grakovitch2, S Trofimik3, O N Polyanskaya2, L Starastsenka2, E K Cahoon1, M Hatch1, M P Little1, A V Brenner1, E Ostroumova1, K Mabuchi1, A V Rozhko2. 1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892-9778, USA. 2. Republican Research Center for Radiation Medicine and Human Ecology, 290 Ilyicha Street, Gomel, 246040, Belarus. 3. Institute for Nuclear Problems, Belarusian State University, 11 Bobruiskaya Street, Minsk, 220006, Belarus. 4. Joint Institute of Informatics Problems, National Academy of Sciences of Belarus, 6 Surhanava Street, Minsk, 220012, Belarus.
Abstract
OBJECTIVE: To describe the status and results of thyroid disease screening and assessment of reliability of radiationthyroid doses in the Belarusian in utero cohort of 2,965 individuals exposed to Chernobyl (Chornobyl) fallout. MATERIALS AND METHODS: Thyroid screening examinations are currently underway including thyroid palpation by anendocrinologist, ultrasonographic examination by an ultrasonographer and analysis of blood samples for diagnosisof hypo- and hyperthyroidism, autoimmune thyroiditis, thyroid function tests (thyroid-stimulating hormone [TSH],thyroxine [T4], thyroid peroxidase antibody [anti-TPO], and thyroglobulin antibodies [anti-TG]). Reliability of (i)information from 780 pairs of questionnaires obtained during the first and second interviews of the mothers and (ii)thyroid doses, which were calculated for the cohort members using this information, is evaluated. RESULTS: As of 15 August 2021, 1,267 in utero exposed study subjects had been screened. A single thyroid nodule wasdiagnosed in 167 persons (13.2 % of the total) and multiple thyroid nodules in 101 persons (8.0 %): 189 (14.9 %)persons had nodules detected for the first time at the screening while 79 (6.2 %) persons had nodules detected pre-viously (pre-screening nodules). Fifty-nine out of 268 subjects (22.0 %) with a suspicious thyroid nodule werereferred to fine needle aspiration biopsy, and among them 33 (55.9 %) were biopsied. Reasonable agreement wasobserved for modelqbased doses calculated for the Belarusian in utero cohort members using data from the two inter-views (Spearman's rank-correlation coefficient rs = 0.74, p < 0.001), while measurementqbased doses yielded almost per-fect agreement (rs = 0.99, p < 0.001). CONCLUSIONS: During the thyroid screening, at least one thyroid nodule was identified in 268 of 1,267 (21.2 %) inutero exposed cohort members. Seven thyroid cancer cases were identified in the cohort, including 5 pre-screeningcases and 2 cases detected during the screening. Ongoing research on this unique cohort will provide importantinformation on adverse health effects following prenatal and postnatal exposure to radioiodine and radiocesium iso-topes, for which available epidemiological data are scant. V. Drozdovitch, V. V. Yauseyenka, V. F. Minenko, I. V. Veyalkin, T. S. Kukhta, R. I. Grakovitch, S. Trofimik, O. N. Polyanskaya, L. Starastsenka, E.K. Cahoon, M. Hatch, M. P. Little, A.V. Brenner, E. Ostroumova, K. Mabuchi, A.V. Rozhko.
OBJECTIVE: To describe the status and results of thyroid disease screening and assessment of reliability of radiationthyroid doses in the Belarusian in utero cohort of 2,965 individuals exposed to Chernobyl (Chornobyl) fallout. MATERIALS AND METHODS: Thyroid screening examinations are currently underway including thyroid palpation by anendocrinologist, ultrasonographic examination by an ultrasonographer and analysis of blood samples for diagnosisof hypo- and hyperthyroidism, autoimmune thyroiditis, thyroid function tests (thyroid-stimulating hormone [TSH],thyroxine [T4], thyroid peroxidase antibody [anti-TPO], and thyroglobulin antibodies [anti-TG]). Reliability of (i)information from 780 pairs of questionnaires obtained during the first and second interviews of the mothers and (ii)thyroid doses, which were calculated for the cohort members using this information, is evaluated. RESULTS: As of 15 August 2021, 1,267 in utero exposed study subjects had been screened. A single thyroid nodule wasdiagnosed in 167 persons (13.2 % of the total) and multiple thyroid nodules in 101 persons (8.0 %): 189 (14.9 %)persons had nodules detected for the first time at the screening while 79 (6.2 %) persons had nodules detected pre-viously (pre-screening nodules). Fifty-nine out of 268 subjects (22.0 %) with a suspicious thyroid nodule werereferred to fine needle aspiration biopsy, and among them 33 (55.9 %) were biopsied. Reasonable agreement wasobserved for modelqbased doses calculated for the Belarusian in utero cohort members using data from the two inter-views (Spearman's rank-correlation coefficient rs = 0.74, p < 0.001), while measurementqbased doses yielded almost per-fect agreement (rs = 0.99, p < 0.001). CONCLUSIONS: During the thyroid screening, at least one thyroid nodule was identified in 268 of 1,267 (21.2 %) inutero exposed cohort members. Seven thyroid cancer cases were identified in the cohort, including 5 pre-screeningcases and 2 cases detected during the screening. Ongoing research on this unique cohort will provide importantinformation on adverse health effects following prenatal and postnatal exposure to radioiodine and radiocesium iso-topes, for which available epidemiological data are scant. V. Drozdovitch, V. V. Yauseyenka, V. F. Minenko, I. V. Veyalkin, T. S. Kukhta, R. I. Grakovitch, S. Trofimik, O. N. Polyanskaya, L. Starastsenka, E.K. Cahoon, M. Hatch, M. P. Little, A.V. Brenner, E. Ostroumova, K. Mabuchi, A.V. Rozhko.
Entities:
Keywords:
Chernobyl; Chornobyl; early life; exposure; in utero; reliability; thyroid cancer
Authors: I Likhtarov; L Kovgan; M Chepurny; O Ivanova; Z Boyko; G Ratia; S Masiuk; V Gerasymenko; V Drozdovitch; V Berkovski; M Hatch; A Brenner; N Luckyanov; P Voillequé; A Bouville Journal: Health Phys Date: 2011-06 Impact factor: 1.316
Authors: Valentin A Stezhko; Elena E Buglova; Larissa I Danilova; Valentina M Drozd; Nikolaj A Krysenko; Nadia R Lesnikova; Victor F Minenko; Vladislav A Ostapenko; Sergey V Petrenko; Olga N Polyanskaya; Valery A Rzheutski; Mykola D Tronko; Olga O Bobylyova; Tetyana I Bogdanova; Ovsiy V Ephstein; Iryna A Kairo; Olexander V Kostin; Ilya A Likhtarev; Valentin V Markov; Valery A Oliynik; Viktor M Shpak; Valeriy P Tereshchenko; Galina A Zamotayeva; Gilbert W Beebe; Andre C Bouville; Aaron B Brill; John D Burch; Daniel J Fink; Ellen Greenebaum; Geoffrey R Howe; Nickolas K Luckyanov; Ihor J Masnyk; Robert J McConnell; Jacob Robbins; Terry L Thomas; Paul G Voillequé; Lydia B Zablotska Journal: Radiat Res Date: 2004-04 Impact factor: 2.841
Authors: Joachim Schüz; Isabelle Deltour; Lyudmila Y Krestinina; Yulia V Tsareva; Evgenia I Tolstykh; Mikhail E Sokolnikov; Alexander V Akleyev Journal: Br J Cancer Date: 2016-11-17 Impact factor: 7.640